Clinical

Dataset Information

Application and exploration of Fuquinitinib combined immunotherapy and SBRT in third-line and beyond treatment of metastatic colorectal cancer


ABSTRACT: Interventions: cohort 1:Fuquinitinib combined sintilimab and SBRT Primary outcome(s): Progression-free survival assessed by the investigator Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 87133 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR